Prostate Cancer - Results from #1340

Astragaloside IV-PESV inhibits prostate cancer tumor growth by restoring gut microbiota and microbial metabolic homeostasis via the AGE-RAGE pathway. April 17, 2024

A Comprehensive Overview of Intraoperative Complications during Retzius-Sparing Robot-Assisted Radical Prostatectomy: Single Series from High-Volume Center. April 17, 2024

Development and validation of a deep learning-based microsatellite instability predictor from prostate cancer whole-slide images. April 17, 2024

Distinct Prostate Cancer Survival Outcomes in Firefighters: A Population-Based Study. April 17, 2024

Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada. April 17, 2024

Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual April 16, 2024

Patient Reported Sexual Adaptation Following Prostate Cancer Treatment: An Analysis of Related Variables and Sexual Outcomes Associated with Sexual Adaptation Styles. April 16, 2024

Biomarkers for Pre-Treatment Risk Stratification of Prostate Cancer Patients: A Systematic Review. April 16, 2024

Precision medicine for prostate cancer: An international perspective. April 16, 2024

Salvage Androgen Deprivation Therapy as Potential Treatment for Recurrence after Robot-Assisted Radical Prostatectomy. April 16, 2024

Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations. April 16, 2024

[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial. April 16, 2024

Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort. April 15, 2024

Enzalutamide: Understanding and Managing Drug Interactions to Improve Patient Safety and Drug Efficacy. April 15, 2024

A Systematic Review of the Association between Psychological Resilience and Improved Psychosocial Outcomes in Prostate Cancer Patients. Could Resilience Training Have a Potential Role? April 15, 2024

First-line combination treatment with PARP and androgen receptor-signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in the United States. April 15, 2024

EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. April 15, 2024

Impact of Family History and Germline Genetic Risk Single Nucleotide Polymorphisms on Long-Term Outcomes of Favorable-Risk Prostate Cancer. April 12, 2024

A Provider-Facing Decision Support Tool for Prostate Cancer Screening in Primary Care: A Pilot Study. April 12, 2024

Long Term Second Malignancies in Prostate Cancer Patients Treated with Low-Dose-Rate Brachytherapy and Radical Prostatectomy. April 12, 2024

Page 68 of 1450